Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/124000
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorIngman, W.V.en
dc.contributor.authorRichards, B.en
dc.contributor.authorStreet, J.M.en
dc.contributor.authorCarter, D.en
dc.contributor.authorRickard, M.en
dc.contributor.authorStone, J.en
dc.contributor.authorDasari, P.en
dc.date.issued2020en
dc.identifier.citationJournal of Clinical Medicine, 2020; 9(3):681-1-681-8en
dc.identifier.issn2077-0383en
dc.identifier.issn2077-0383en
dc.identifier.urihttp://hdl.handle.net/2440/124000-
dc.description.abstractBreast density, also known as mammographic density, refers to white and bright regions on a mammogram. Breast density can only be assessed by mammogram and is not related to how breasts look or feel. Therefore, women will only know their breast density if they are notified by the radiologist when they have a mammogram. Breast density affects a woman’s breast cancer risk and the sensitivity of a screening mammogram to detect cancer. Currently, the position of BreastScreen Australia and the Royal Australian and New Zealand College of Radiologists is to not notify women if they have dense breasts. However, patient advocacy organisations are lobbying for policy change. Whether or not to notify women of their breast density is a complex issue and can be framed within the context of both public health ethics and clinical ethics. Central ethical themes associated with breast density notification are equitable care, patient autonomy in decision-making, trust in health professionals, duty of care by the physician, and uncertainties around evidence relating to measurement and clinical management pathways for women with dense breasts. Legal guidance on this issue must be gained from broad legal principles found in the law of negligence and the test of materiality. We conclude a rigid legal framework for breast density notification in Australia would not be appropriate. Instead, a policy framework should be developed through engagement with all stakeholders to understand and take account of multiple perspectives and the values at stake.en
dc.description.statementofresponsibilityWendy V. Ingman, Bernadette Richards, Jacqueline M. Street, Drew Carter, Mary Rickard, Jennifer Stone, and Pallave Dasarien
dc.language.isoenen
dc.publisherMDPI AGen
dc.rights© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).en
dc.source.urihttp://www.mdpi.com/journal/jcmen
dc.subjectBreast density; mammographic density; mammogram; breast cancer screening; clinical ethics; health policy; duty of careen
dc.titleBreast density notification: an Australian perspectiveen
dc.typeJournal articleen
dc.identifier.rmid1000016894en
dc.identifier.doi10.3390/jcm9030681en
dc.identifier.pubid522704-
pubs.library.collectionLaw publicationsen
pubs.library.teamDS06en
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
dc.identifier.orcidIngman, W.V. [0000-0003-3116-2902]en
dc.identifier.orcidRichards, B. [0000-0001-6448-4954]en
dc.identifier.orcidStreet, J.M. [0000-0002-1033-4341]en
dc.identifier.orcidCarter, D. [0000-0002-1221-6656]en
dc.identifier.orcidDasari, P. [0000-0001-8399-1740]en
Appears in Collections:Law publications

Files in This Item:
File Description SizeFormat 
hdl_124000.pdfPublished version613.73 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.